DGCI gives nod for phase 2/3 trials of Biological E jab on kids

New Delhi, Sep 01: The Drugs Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its 'Made in India' COVID-19 vaccine on children aged between 5 and 18 years

from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/3kJteTa

• Tweet
• Share
• Share
• Share
• Share

About Admin MC3

This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.

Related Post